— Know what they know.
Not Investment Advice

CERE NASDAQ

Cerevel Therapeutics Holdings, Inc.
1W: +1.3% 1M: +9.1% 3M: +5.5% 1Y: +46.7% 3Y: +79.5%
$44.96
Last traded 2024-08-01 — delisted
NASDAQ · Healthcare · Biotechnology · $8.2B mcap · 78M float · 2.71% daily turnover
No technical data available for CERE

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms